5//SEC Filing
LOF PARTNERS LLC 5
Accession 0001181431-13-010400
CIK 0000810084other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 12:25 PM ET
Size
14.8 KB
Accession
0001181431-13-010400
Insider Transaction Report
Form 5
Transactions
- Other
Series G Preferred Stock
2011-03-10+6,012→ 50,335 totalExercise: $13.00From: 2011-03-10→ Common Stock (601,200 underlying) - Other
Series G Preferred Stock
2011-03-10+1,076→ 10,741 totalExercise: $13.00From: 2011-03-10→ Common Stock (107,600 underlying)
LOF PARTNERS LLC
Other
Transactions
- Other
Series G Preferred Stock
2011-03-10+1,076→ 10,741 totalExercise: $13.00From: 2011-03-10→ Common Stock (107,600 underlying) - Other
Series G Preferred Stock
2011-03-10+6,012→ 50,335 totalExercise: $13.00From: 2011-03-10→ Common Stock (601,200 underlying)
GALE JAMES C
Director
Transactions
- Other
Series G Preferred Stock
2011-03-10+1,076→ 10,741 totalExercise: $13.00From: 2011-03-10→ Common Stock (107,600 underlying) - Other
Series G Preferred Stock
2011-03-10+6,012→ 50,335 totalExercise: $13.00From: 2011-03-10→ Common Stock (601,200 underlying)
Transactions
- Other
Series G Preferred Stock
2011-03-10+1,076→ 10,741 totalExercise: $13.00From: 2011-03-10→ Common Stock (107,600 underlying) - Other
Series G Preferred Stock
2011-03-10+6,012→ 50,335 totalExercise: $13.00From: 2011-03-10→ Common Stock (601,200 underlying)
Footnotes (4)
- [F1]These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by Signet Healthcare Partners, LLC, the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer and manager of Signet Healthcare Partners, LLC, and SMW Investments I, LLC, the controlling member of Signet Healthcare Partners, LLC. Signet Healthcare Partners, LLC, SMW Investments I, LLC, and James C. Gale disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.
- [F2]These securities are owned directly by Life Sciences Opportunities Fund II (Institutional), L.P. and indirectly by Signet Healthcare Partners, LLC, the general partner of Life Sciences Opportunities Fund II (Institutional), L.P., James C. Gale, the chief investment officer and manager of Signet Healthcare Partners, LLC, and SMW Investments I, LLC, the controlling member of Signet Healthcare Partners, LLC. Signet Healthcare Partners, LLC, SMW Investments I, LLC, and James C. Gale disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.
- [F3]Series G Convertible Preferred Stock issued as stock dividend pursuant to the terms of a Purchase Agreement dated as of December 18, 2009. The Shares are convertible at any time by the purchasers into Commn Stock at the rate 100 shares of Common Stock per each shares of Series G Preferred Stock or $0.13 per share. LOF and LOFI paid for the Series G Preferred by the cancellation of the $600,000 outstanding principal amount of and $101,834.06 accrued interest through December 18, 2009 on the 2007 Convertible Subordinated Promissory Notes dated as of December 5, 2007
- [F4]None
Documents
Issuer
BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001280952
Filing Metadata
- Form type
- 5
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 12:25 PM ET
- Size
- 14.8 KB